Dose-dependent changes in cyclin D1 in response to 4-nitroquinoline 1-oxide-induced DNA damage

Archives of Biochemistry and Biophysics

Volumn 497, Issue 1-2, 2010, Pages 55-61

  Suwaki, Natsuko ^a   Child, Emma S ^a   Elphick, Lucy M ^a   Mann, David J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

4NQO; Cyclin D1; DNA damage; P21CIP1; P53; Retinoblastoma protein

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; DNA; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ARTICLE; CELL DEATH; CONTROLLED STUDY; DNA DAMAGE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

4-NITROQUINOLINE-1-OXIDE; ANIMALS; ANTINEOPLASTIC AGENTS; CELL SURVIVAL; CULTURE MEDIA, SERUM-FREE; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; MICE; MUTAGENS; NIH 3T3 CELLS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77952545058     PISSN: 00039861     EISSN: 10960384     Source Type: Journal    
DOI: 10.1016/j.abb.2010.03.003     Document Type: Article

References (28)

1. Matsushime H., Ewen M.E., Strom D.K., Kato J.Y., Hanks S.K., Roussel M.F., Sherr C.J. Cell 1992, 71:323-334.
2. Matsushime H., Quelle D.E., Shurtleff S.A., Shibuya M., Sherr C.J., Kato J.Y. Mol. Cell. Biol. 1994, 14:2066-2076.
3. Sherr C.J., Kato J., Quelle D.E., Matsuoka M., Roussel M.F. Cold Spring Harb. Symp. Quant. Biol. 1994, 59:11-19.
4. Connell-Crowley L., Harper J.W., Goodrich D.W. Mol. Biol. Cell. 1997, 8:287-301.
5. Hatakeyama M., Brill J.A., Fink G.R., Weinberg R.A. Genes Dev. 1994, 8:1759-1771.
6. Resnitzky D., Reed S.I. Mol. Cell. Biol. 1995, 15:3463-3469.
7. Sherr C.J. Trends Biochem. Sci. 1995, 20:187-190.
8. Agami R., Bernards R. Cell 2000, 102:55-66.
9. Barnouin K., Dubuisson M.L., Child E.S., Fernandez de Mattos S., Glassford J., Medema R.H., Mann D.J., Lam E.W. J. Biol. Chem. 2002, 277:13761-13770.
10. Hiyama H., Iavarone A., LaBaer J., Reeves S.A. Oncogene 1997, 14:2533-2542.
11. Miyakawa Y., Matsushime H. Biochem. Biophys. Res. Commun. 2001, 284:71-76.
12. Yang A.L., Zdzienicka M.Z., Simons J.W., Waters R. Mutagenesis 1991, 6:449-453.
13. Zelle B., Bootsma D. Mutat. Res. 1980, 70:373-381.
14. Burma S., Chen B.P., Murphy M., Kurimasa A., Chen D.J. J. Biol. Chem. 2001, 276:42462-42467.
15. Paull T.T., Rogakou E.P., Yamazaki V., Kirchgessner C.U., Gellert M., Bonner W.M. Curr. Biol. 2000, 10:886-895.
16. Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., Bonner W.M. J. Biol. Chem. 1998, 273:5858-5868.
17. Mittnacht S. Curr. Opin. Genet. Dev. 1998, 8:21-27.
18. Knudsen E.S., Wang J.Y. J. Biol. Chem. 1996, 271:8313-8320.
19. Zarkowska T., Mittnacht S. J. Biol. Chem. 1997, 272:12738-12746.
20. Sherr C.J., Roberts J.M. Genes Dev. 1995, 9:1149-1163.
21. Sherr C.J., Roberts J.M. Genes Dev. 1999, 13:1501-1512.
22. Gu Y., Rosenblatt J., Morgan D.O. EMBO J. 1992, 11:3995-4005.
23. Donzelli M., Draetta G.F. EMBO Rep. 2003, 4:671-677.
24. Falck J., Mailand N., Syljuasen R.G., Bartek J., Lukas J. Nature 2001, 410:842-847.
25. Cory A.H., Owen T.C., Barltrop J.A., Cory J.G. Cancer Commun. 1991, 3:207-212.
26. Taylor E.M., Lehmann A.R. Int. J. Radiat. Biol. 1998, 74:277-286.
27. Tsujimoto Y., Nakagawa T., Shimizu S. Biochim. Biophys. Acta 2006, 1757:1297-1300.
28. Kim R., Emi M., Tanabe K. Cancer Chemother. Pharmacol. 2006, 57:545-553.